Project Grant R01NS138305

Award Date 7/18/25
Completion Date 6/30/30
Dollars Obligated $653K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Charlestown, MA 02129, USA
Similar Awards
This $1,361,648 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support a multi-scale, multi-modal longitudinal imaging study to examine the association of cognitive function with changes in brain structure, function, and neuronal integrity in patients with multiple sclerosis (MS). The primary research objectives are to: 1)...
The federal Project Grant award of $621,500 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The goal of the project is to develop new methods for combined molecular and ultrastructural imaging of neural cells and tissues using advanced nanoprobes and cathodoluminescent dyes. Specifically, the award will fund the development of (1) detergent-free...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a pilot study to evaluate the feasibility of using non-invasive neuroimaging techniques to monitor the metabolic and vascular functions of the brain and heart in a mouse model of Alzheimer's disease (AD). The $332,096 award, with a performance period from July 2024 to June 2026, will be made to The General Hospital Corporation (doing business as Massachusetts General Hospital). The research...
The federal Project Grant award in the amount of $999,940.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for the project "DEVELOPMENT OF IMAGING OUTCOME MEASURES OF NEUROPROTECTION IN MULTIPLE SCLEROSIS USING ULTRA-HIGH GRADIENT DIFFUSION MRI". The award period is from June 1, 2024 to May 31, 2027. Through this grant, MGH...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $798,848.00 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to investigate the role of the skull bone marrow niche in post-stroke inflammation and recovery. The project aims to examine the information transfer between the central nervous...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $541,109 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the University of Washington. The 5-year grant, beginning January 1, 2025, will fund research to quantify myelin loss and recovery in ischemic stroke patients using a novel magnetic resonance imaging (MRI) technique called single-point macromolecular proton fraction (MPF) mapping. The...
This Project Grant award of $2,156,000.00 from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) supports a research project to develop and validate non-invasive neuroimaging methods for quantifying brain oxygen availability, pH, and carbon dioxide levels. The goal is to better understand the relationship between cerebral blood flow, neuronal metabolic demands, and the regulation of waste products, in order to identify the underlying causes of brain...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $431,750.00 to develop a new whole-brain PET-based molecular neuroimaging technique for non-invasively mapping neuronal circuit activity in awake mammals. The goal is to create a tool that can identify neuronal circuits involved in complex behaviors and cognitive tasks, which can...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $630,982.00 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct a comprehensive study on neuroprotective strategies for patients undergoing aortic arch surgery. The study aims to assess the effectiveness of different brain...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853), provides $776,503 to The General Hospital Corporation (Massachusetts General Hospital) to investigate the role of perivascular inflammation and vascular remodeling in cerebral small vessel diseases (CSVD), which can lead to intracerebral hemorrhage. The project will leverage autopsy cases and mouse...

This federal Project Grant award, totaling $653,192.00 and provided by the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders, supports a longitudinal study on non-invasive imaging of pathological fibrin deposition and its effects on progressive neurodegeneration in the human brain. The study, conducted by the primary awardee The General Hospital Corporation (doing business as Massachusetts General Hospital), aims to establish an in vivo link between fibrin deposition and detrimental brain structural pathology in progressive multiple sclerosis (MS). The research will utilize a novel 64Cu-FBP8 brain positron emission tomography (PET) imaging approach combined with magnetic resonance imaging (MRI) techniques to quantify fibrin deposition and assess its relationship to myelin damage and cortical lesions in MS patients. The award period runs from July 18, 2025 to June 30, 2030.

Generated 8/5/25, 5:07 AM